News

In her latest blog, Joy Gibb, ABOC writes why allowing staff more learning opportunities builds better office morale.

In his latest blog, Mark Packer, MD, FACS, CPI, defends why doctors should not allow the restrictions of third party payers on reimbursement for cataract surgery to drive your diagnosis or your recommendations for treatment, as diagnosis and treatment must remain the surgeon’s sole responsibility if our profession is to retain any of its natural inherent authority.

When weighing the decision to adopt minimally invasive glaucoma surgery (MIGS) into their practice, several advantages may support surgeons’ rationale, according to Richard A. Lewis, MD.

Novartis attempted to block studies in the United Kingdom comparing ranibizumab (Lucentis) and bevacizumab (Avastin) for the treatment of wet age-related macular degeneration (AMD), according to an article published in The BJM, an international peer-reviewed medical journal.

In his debut blog, Arun C. Gulani, MD, recalls the great power of what ophthalmologists can really do for their patients.

Several decades of advances in techniques and technology have enabled surgeons to improve the outcomes of treatment for orbital fractures.

Keratoneuralgia, also known as “pain without stain” is primarily a clinical diagnosis made for patients with corneal pain symptoms with minimal-to-no clinical signs and minimally, if at all, relieved by conventional dry eye treatments.

A new capsule polisher can efficiently polish and sweep debris from the entire anterior capsule.

This year’s simultaneous meeting of the American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators will convene in San Diego from April 17 to 21.

Conbercept is an anti-vascular endothelial growth factor (VEGF) drug approved for the treatment of wet age-related macular degeneration in China. Compared with agents used in the United States, it has a higher binding affinity, lower VEGF dissociation rate, and longer clearance time.

Following successful EHR implementation, a practice administrator shares how he and colleagues make good use of its rewards.

The unique properties of a light-adjustable lens are designed to provide predictable results and customized refractive treatments.

Early experience with a new intrastromal corneal ring segment arc length appears to be a valuable addition to the keratoconus treatment armamentarium for one surgeon.

Three main attributes for swept-source optical coherence tomography involve deeper range of imaging into the eye, less sensitivity roll-off with depth, and faster scanning speed.

In this first of a two-part series Arun C. Gulani, MD, discusses how pterygium and pinguecula surgery can be approached cosmetically, even in extensive cases, and not only improved pathologically and functionally but also raised to a cosmetic outcome. Part 2 will address strategies for handling complex and recurrent pterygium surgery and complications such as scleral melts.

With the availability of a new slit lamp (Xcel 455, Reichert Technologies) also comes the ability for clinicians to switch easily to higher magnifications-further improving diagnosis and treatment-in a cost-effective instrument.

As everyone knows, teenage girls have the knack of identifying the important new trends that come to define our culture: boy bands, Miley Cyrus, Justin Bieber, and reality television. For this reason, I became instantly alert when Dean, a talented ophthalmologist and loyal Ophthalmology Times reader, contacted me one evening about what was shortly to become the latest Internet sensation.

Joseph Tauber, MD, has found in his experience as an active clinical research that listening to patients may be the greatest diagnostic tool for ocular surface disease.

When deciding which steroid option may be best for treating patients with thyroid eye disease, first identify the severity and activity of the condition.

Endothelial keratoplasty makes it easier to follow patients with glaucoma and lowers the risk of ocular surface disease.

Participating in clinical trials can be rewarding. Not every eye-care practice is set-up for participation in clinical trials, but for those that invest the time and energy to become a high-quality research center, the benefits to both practice and patients can be quite significant.

Immunomodulatory therapy for ocular inflammatory disease can be potent and effective, but physicians should be patient while awaiting results-and watch carefully for complications.

SAKURA is a 24-month phase III study investigating the efficacy and safety of intravitreal sirolimus for treatment of noninfectious posterior segment uveitis. Data were reported from the primary endpoint visit at 5 months.

Though making the switch to electronic technology may generate some built-in efficiency, is it a reach to suggest its use boosts quality of care? One expert explores the costs and factors.

Despite the advent of advanced technologies-such as corneal stromal collagen crosslinking (CXL), intracorneal ring segments (ICRS), toric phakic and pseudophakic IOLs, and keratoplasty-patients with keratoconus are mostly being managed with spectacles and/or contact lenses.

In her debut blog, Donna Suter, president of Suter Consulting Group, writes why patient perception of your office can be emotion-laden and as quick as a hail storm of controversy because patient care puts you and your team in a fish bowl.

The activity in age-related macular degeneration (AMD) involves a close association between endothelial cells and pericytes, the latter of which wraps around endothelial cells of the capillaries and venules.Pericytes regulate blood flow, clear cellular debris, are a key factor in the blood-brain barrier, and stabilize maturation of endothelial cells, explained Elias Reichel, MD, professor of ophthalmology, Tufts University School of Medicine, and vice chairman, New England Eye Center, Boston.

In her debut Blog, Joy Gibb, ABOC, encourages physicians to daydream with their team to create their ideal practice.